ArticleBreast cancer research and treatment2025
Potential candidates for adjuvant olaparib treatment in operable breast cancer patients with germline BRCA1/2 pathogenic variants after neoadjuvant chemotherapy.
Huimin Liu et al.PubMed ↗Publisher ↗
No numbers read from the abstract.